Novozymes A/S
NVZMF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $180,352,785 | $100,139,710 | $97,476,228 | $149,525,094 |
| - Cash | $280,000 | $1,116,000 | $1,041,000 | $963,000 |
| + Debt | $1,796,800 | $7,733,000 | $919,082 | $482,000 |
| Enterprise Value | $181,869,585 | $106,756,710 | $97,354,310 | $149,044,094 |
| Revenue | $28,590,094 | $17,905,937 | $17,553,000 | $14,951,000 |
| % Growth | 59.7% | 2% | 17.4% | – |
| Gross Profit | $14,866,700 | $9,725,946 | $9,590,000 | $8,638,000 |
| % Margin | 52% | 54.3% | 54.6% | 57.8% |
| EBITDA | $8,071,006 | $5,642,659 | $5,721,000 | $5,061,000 |
| % Margin | 28.2% | 31.5% | 32.6% | 33.9% |
| Net Income | $2,280,645 | $3,025,568 | $3,676,000 | $3,146,000 |
| % Margin | 8% | 16.9% | 20.9% | 21% |
| EPS Diluted | 0.67 | 10.88 | 13.19 | 11.23 |
| % Growth | -93.8% | -17.5% | 17.5% | – |
| Operating Cash Flow | $1,019,900 | $4,152,000 | $4,006,000 | $4,062,000 |
| Capital Expenditures | -$359,800 | -$2,056,000 | -$2,890,000 | -$1,240,000 |
| Free Cash Flow | $660,100 | $2,096,000 | $1,116,000 | $2,822,000 |